Desmoid Tumor: Clinical Trials

1 trial for Desmoid Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Desmoid Tumor: new trials by email Literature Review of Desmoid Tumor trials Research Report on Desmoid Tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Nirogacestat - Desmoid Tumor, Aggressive Fibromatosis
Phase 4RecruitingSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany502025-09-172026-11-09

Narrower conditions

Desmoid Tumors (1)

Broader conditions

Fibroma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Fibrous Tissue (1)

Interventions

nirogacestat (1)

Sponsors

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)